(Q53589371)

English

The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.

scientific article published on 18 March 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

12

object named as

Arndt Hartmann

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

author name string

Sven Wach

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Omar Al-Janabi

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Katrin Weigelt

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Kersten Fischer

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Thomas Greither

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Marios Marcou

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Gerit Theil

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Elke Nolte

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Hans-Juergen Holzhausen

9

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Robert Stöhr

10

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Verena Huppert

11

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Paolo Fornara

13

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Bernd Wullich

14

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Helge Taubert

15

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

language of work or name

0 references

publication date

18 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

137

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

1406-1416

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

microRNA biomarkers in body fluids of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Novel tools for prostate cancer prognosis, diagnosis, and follow-up

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Bloodborne biomolecular markers in prostate cancer development and progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Tumor markers in prostate cancer I: blood-based markers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

The emerging role of miR-375 in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

The microRNA profile of prostate carcinoma obtained by deep sequencing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Changes in circulating microRNA levels associated with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Androgen regulation of micro-RNAs in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

A panel of five circulating microRNAs as potential biomarkers for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

The urokinase plasminogen activator system: role in malignancy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Involvement of urokinase-type plasminogen activator system in cancer: an overview

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Association of tissue mRNA and serum antigen levels of members of the urokinase-type plasminogen activator system with clinical and prognostic parameters in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Analyzing real-time PCR data by the comparative C(T) method

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Extracellular microRNAs in urologic malignancies: chances and challenges

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

miR-375 maintains normal pancreatic alpha- and beta-cell mass

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival

1 reference

https://api.crossref.org/works/10.1002%2FIJC.29505

21 January 2018

Identifiers

10.1002/IJC.29505

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25754273

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53589371&oldid=1879006588"